Literature DB >> 35685259

A case of chronic myocarditis remitted by immunosuppressive and central extracorporeal membrane oxygenation therapy.

Makiko Nakamura1, Teruhiko Imamura1, Yuki Hida1, Akira Oshima1, Shigeki Yokoyama2, Toshio Doi2, Kazuaki Fukahara2, Koichiro Kinugawa1.   

Abstract

The concept and therapeutic strategy for chronic lymphocytic myocarditis remain unestablished. We had a 57-year-old man with advanced biventricular (predominantly right ventricular) failure due to chronic lymphocytic myocarditis. He received central extracorporeal membrane oxygenation therapy that was explanted on day 129 following the aggressive steroid pulse and plasma exchange therapy. Infiltration of inflammatory cells persisted even after the device removal, which required long-term oral steroid administration after the index discharge on day 200. High-sensitivity cardiac troponin T level was normalized and inflammatory cell infiltration was remitted following post-discharge 4-month 10 mg/day prednisolone therapy. Aggressive immunosuppressive therapy under mechanical circulatory support might be a promising strategy for those with chronic lymphocytic myocarditis. <Learning objective: "Chronic myocarditis" does not exist as a formal classification of myocarditis worldwide and therapeutic strategy remains controversial. Aggressive immunosuppressive therapy under mechanical circulatory support might be a promising strategy for chronic lymphocytic myocarditis.>.
© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Corticosteroids; Mechanical circulatory support; Unloading

Year:  2021        PMID: 35685259      PMCID: PMC9169008          DOI: 10.1016/j.jccase.2021.12.005

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  8 in total

1.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Alida L P Caforio; Sabine Pankuweit; Eloisa Arbustini; Cristina Basso; Juan Gimeno-Blanes; Stephan B Felix; Michael Fu; Tiina Heliö; Stephane Heymans; Roland Jahns; Karin Klingel; Ales Linhart; Bernhard Maisch; William McKenna; Jens Mogensen; Yigal M Pinto; Arsen Ristic; Heinz-Peter Schultheiss; Hubert Seggewiss; Luigi Tavazzi; Gaetano Thiene; Ali Yilmaz; Philippe Charron; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-07-03       Impact factor: 29.983

2.  Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version.

Authors: 
Journal:  Circ J       Date:  2011-02-04       Impact factor: 2.993

3.  Guideline for diagnosing chronic myocarditis. Japanese Circulation Society (JCS) Task Force Committee on Chronic Myocarditis.

Authors: 
Journal:  Jpn Circ J       Date:  1996-05

Review 4.  Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment.

Authors:  Enrico Ammirati; Giacomo Veronese; Manlio Cipriani; Francesco Moroni; Andrea Garascia; Michela Brambatti; Eric D Adler; Maria Frigerio
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

5.  Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association.

Authors:  Robb D Kociol; Leslie T Cooper; James C Fang; Javid J Moslehi; Peter S Pang; Marwa A Sabe; Ravi V Shah; Daniel B Sims; Gaetano Thiene; Orly Vardeny
Journal:  Circulation       Date:  2020-01-06       Impact factor: 29.690

6.  Mode-of-action of the PROPELLA concept in fulminant myocarditis.

Authors:  Frank Spillmann; Sophie Van Linthout; Gunther Schmidt; Oliver Klein; Nazha Hamdani; Thomas Mairinger; Florian Krackhardt; Bastian Maroski; Thomas Schlabs; Sajjad Soltani; Stefan Anker; Evgenij V Potapov; Daniel Burkhoff; Burkert Pieske; Carsten Tschöpe
Journal:  Eur Heart J       Date:  2019-07-01       Impact factor: 29.983

Review 7.  Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.

Authors:  Carsten Tschöpe; Enrico Ammirati; Biykem Bozkurt; Alida L P Caforio; Leslie T Cooper; Stephan B Felix; Joshua M Hare; Bettina Heidecker; Stephane Heymans; Norbert Hübner; Sebastian Kelle; Karin Klingel; Henrike Maatz; Abdul S Parwani; Frank Spillmann; Randall C Starling; Hiroyuki Tsutsui; Petar Seferovic; Sophie Van Linthout
Journal:  Nat Rev Cardiol       Date:  2020-10-12       Impact factor: 49.421

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.